Jeffrey Mangel

MetroHealth Medical Center

Papers

2

Total Citations

13

H-Index

2

About

Jeffrey Mangel is a leading voice in female pelvic medicine and reconstructive surgery (FPMRS), with a research focus sharpened on the intersection of surgical outcomes and systemic patient safety. His work critically examines the risks inherent in pelvic organ prolapse (POP) repair, particularly through his landmark survey on the adoption of opportunistic salpingectomy during prolapse surgery, which has garnered 9 citations and helped shape evolving prophylactic practices. Dr. Mangel’s most impactful contribution is his pioneering investigation into major adverse cardiovascular and cerebrovascular events (MACCE) following female pelvic reconstructive surgery. His 2020 study, cited 4 times, leveraged national inpatient data to establish crucial benchmarks for perioperative cardiovascular risk, directly informing preoperative counseling and surgical planning for a growing, often older, patient population. By bridging gynecologic surgery with internal medicine, Dr. Mangel provides a vital framework for minimizing life-threatening complications. His work stands as a critical resource for surgeons and trainees aiming to balance reconstructive efficacy with comprehensive patient well-being.

Research Focus

Key Achievements

2
H-Index
2
Papers
13
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Survey of pelvic reconstructive surgeons on performance of opportunistic salpingectomy at the time of pelvic organ prolapse repair
9 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: MetroHealth Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago